Holiday reporting has garbled most metrics. Going by current COVID-19 hospitalizations, outbreaks in the Midwest are still easing, but every other region is in trouble.
States provide COVID-19 data in a variety of sources and formats. To ensure our data is as accurate and consistent as possible, we spend a lot of time looking at these sources to make sure that we’re capturing the most data possible for each state, while maintaining high standards of data quality and integrity. Today, we’re publicly releasing a detailed set of notes on the sources of all our data points.
Once limited to molecular tests, the United States now has other testing methods available. Their efficacy depends on multiple factors, including how far the person tested is in their infection and how high the test positivity is where they live.
The upcoming holiday means that many COVID-19 metrics are going to drop—and then rise—in ways that may trip up unsuspecting observers. Here’s what to watch out for.
To successfully manage the pandemic, we need tools for both surveillance and diagnosis, in the form of antigen tests and PCR tests.
The announcement of a forthcoming national pandemic dashboard is heartening news for COVID-19 data folks all over the country. We have a few modest suggestions for the team that will undertake this work.
Florida is now publishing a full time series of test encounters, so we are picking up this metric in our API and on our website.
As COVID-19 cases rise across the United States, claims are circulating that case increases are (mostly or entirely) due to expanded testing, and do not indicate a spike in infections. The data does not support this conclusion.
Antigen tests are becoming a major tool for rapid COVID-19 testing. But if states don’t report results clearly, we won’t know the true impact of these tests.
Interpreted correctly, test positivity can tell us so much that we need to know about COVID-19 outbreaks and testing in the United States. But we don’t publish test positivity calculations for US states and territories. Here’s why.
Test positivity is extremely useful, but it has also become one of the most commonly misunderstood metrics for monitoring the COVID-19 pandemic. Here, we take a step back and look at what it really means.
Though cases are rising in parts of the Midwest, hospitalizations in the West and South continued trending downward. The Labor Day holiday impacted data reporting lag times both this week and last, obscuring what had been positive trends in September.
A long holiday weekend makes ambiguous testing data even harder to understand, but hospitalizations are dropping, which is good.
After five straight weeks of sharp declines in new cases of COVID-19 in the United States, we’ve leveled off again. Reported tests are up about 5 percent, but are actually dropping in the Midwest, where three states—Iowa, North Dakota, and South Dakota—are driving an uptick in new cases. This week we also launched a new dataset that looks closely at the toll of COVID-19 in nursing homes and other long-term care facilities.
According to the official state numbers, COVID-19 testing has dropped dramatically in August. However, county-level statistics show the opposite story. What’s going on?
Many states have moved toward greater transparency about their test data reporting methods, and we’re making changes to better represent what they publish. We’re also introducing a “new” way some states are counting tests—one we think all states and territories would be wise to embrace.
Testing continues to fall, especially in the South, one of the areas where the country needs it the most. Cases, too, are falling, which remains hard to interpret, given the testing decline—but fewer people are now in the hospital with COVID-19 than last week. This is the second week in a row that hospitalizations seem to have dropped, which suggests that infections may be declining independently of testing reductions.
Florida’s Per-Capita COVID-19 Cases Just Surpassed New York’s, but Are the Two Outbreaks Comparable? Yes and No.
Florida has reported over 461,000 total COVID-19 cases, surpassing New York for the highest per-capita caseload in the United States—but a simple comparison doesn’t represent the critical differences in the data we have for the two outbreaks.
The South continues to be the epicenter of surges in both cases and hospitalizations. In Arizona, Florida, South Carolina, and Texas, COVID-19 deaths have begun to climb following jumps in new cases. And for the first time since April, deaths are rising nationally.
The US has broken its record for new COVID-19 cases three times in the last week. Thirteen states broke their new-case records since Sunday. In the states with the worst outbreaks, hospitalizations and deaths are rising.
As exposure risk increases, so does the need for more testing. The more we test, the more cases we can identify—which is a good thing. But are we looking at the right metrics to know if we are performing enough tests?
Starting in August, new federal rules will require testing labs to report better data on the spread of COVID-19 in the United States. What happens to this new information is up to state and local officials. Journalists, open-data advocates, and members of the public can help us hold governments accountable for collecting and publishing this urgently needed data.
The United States hit a record high for new COVID-19 cases this week. In many areas with rising case counts, testing isn’t keeping up. Meanwhile, hospitalizations in regions with big outbreaks are increasing.
As case counts surge, we look at regional and state-level numbers to find out which recent jumps in COVID-19 case counts are likely to be explained by increased testing, and which are not. For the states with the worst recent numbers, the news is not good.
As cases and hospitalizations continue to drop in the early Northeast epicenters, they are rising—in some areas quite sharply—in the South and West. We look at the numbers and at the relationship between an increase in tests and a rise in case counts.
Probable cases of COVID-19 make up only a small fraction of currently reported cases, but the CDC wants states to do a better job reporting them. So what are they and why do they matter? We took a closer look to help reporters and members of the public better understand this complex COVID-19 metric.
The news this week is mixed and highly regional. In the early US epicenter of the outbreak, cases continue to drop. In the southern and western United States, cases are on the rise, as are COVID-19 hospitalizations. And as always, the lag makes the data difficult to put into context.
For months, we've worked to patch together inconsistent state-reported data into a national set of numbers for COVID-19 case, death, and testing in the US. The CDC has now published a COVID Data Tracker, but their data only partially matches the numbers we get from the state public health authorities. So we took a closer look.
As antibody tests become more widely available across the United States, we call on all states and territories to preserve the integrity and usefulness of their COVID-19 testing data by maintaining separate viral testing and antibody testing counts.